ATSDR
Environmental Medicine | CSEM | GREM | Continuing Education | Patient Education | PEHT | Community
Section Contents
Learning Objectives
Introduction
Acute Exposure
Chronic Exposure
Risk Communication
Key Points
Progress Check
 
Case Contents
Table of Contents
Cover Page
How to Use This Course
Initial Check
What are PAHs?
Where Found
Exposure Pathways
Who Is at Risk
Standards, Regulations
Biological Fate
Pathogenic Changes
Health Effects
Clinical Assessment
Instructions to Patients
More Information
Posttest
Literature Cited
Printer-Friendly Printer-Friendly
 
Environmental Medicine
CSEM
GREM
PEHT
Continuing Education
Online Registration
Patient Education
Community Education
 
ATSDR Resources
ATSDR en Español
Case Studies (CSEM)
Exposure Pathways
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
CDC
Cancer
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA

Agency for Toxic Substances and Disease Registry 
Case Studies in Environmental Medicine (CSEM) 
Toxicity of Polycyclic Aromatic Hydrocarbons (PAHs)
How Should Patients Exposed to PAHs Be Treated and Managed?

Learning Objectives

Upon completion of this section, you will be able to

  • identify strategies for managing patients with acute high dose PAH exposure, and
  • identify strategies for managing patients with chronic low level PAH exposure.

Introduction

The management and treatment focus of individuals exposed to PAHs differs for high dose acute and low dose chronic exposures. Decontamination and supportive measures are the primary objectives after acute high dose PAH exposure. Treatment of chronic PAH toxicity is symptomatic and supportive. Health education and risk communication are important aspects of patient care. Some clinicians recommend periodic pulmonary function tests and chest x-rays for PAH-exposed individuals (inhalation exposures).

Acute High Dose Exposure

Decontamination and supportive measures are the primary objectives after acute high dose PAH exposure. Acute symptoms are generally from co-exposures to other substances.

Contaminated clothing should be removed from the victim as soon as possible. The victim’s skin should be decontaminated by gently scrubbing with soap and water. Ocular contamination should be treated with irrigation and a complete eye examination. Supportive care should be administered as clinically necessary.

Chronic Exposure and Toxicity

Effective risk communication and education for patients at risk for PAH-related disease is an important part of patient care. Persons exposed to potentially significant levels of PAHs should be aware of the increased risk for bronchogenic cancer and the additive effect of cigarette smoke and other toxic agents. Periodic evaluations of healthy patients who have been significantly exposed to PAHs, even in the absence of symptoms, may facilitate early diagnosis and intervention if a malignancy develops.

The OSHA coke oven emissions standard includes elements of medical surveillance for workers exposed to coke oven emissions. It should be noted that OSHA recommended surveillance (set at the time of the standard) may not necessarily be consistent with current evidenced based medical practice.

Risk Communication in Patient Care

Because estimation of additional risk due to PAH exposure is often impossible, the challenge to the clinician is to maintain a balance between appropriate concern and undue alarm.

Predicting the carcinogenicity of a complex chemical mixture based on one or several of its components is difficult because of possible interactions among the components.

Effective risk communication takes this into account and can be important in prevention or management of disease.

Key Points

  • Decontamination and supportive measures are the primary objectives after acute high dose PAH exposure.
  • Treatment of chronic PAH toxicity is generally symptomatic and supportive.
  • Effective risk communication and health education are important aspects of patient care.
  • Periodic evaluations of healthy patients who have been significantly exposed to PAHs, even in the absence of symptoms, is recommended by some clinicians to facilitate early diagnosis and intervention if a malignancy develops.

Progress Check



Choose the best answer.

19.

Primary strategies for managing patients with acute high dose exposure to PAH include(s) which of the following?

A. Removal of contaminated clothing.
B. Cleansing of skin with soap and water.
C. Supportive care as clinically indicated.
D. All of the above.

Answer:

To review relevant content, see Acute High Dose Exposure in this section.

20.

When managing patients with chronic low level exposure to PAH, strategies aimed at reducing patient risk of overexposure to PAHs and PAH related disease include (s) which of the following?

A. Smoking cessation.
B. Patient health education.
C. Periodic evaluations for those significantly exposed.
D. All of the above.

Answer:

To review relevant content, see Risk Communication in Patient Care in this section.

Previous Section

Next Section

Revised 2008-07-01.